Contact Us

Focus

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

Focus

Feb 7, 2025

Channel Factory partners with Dentsu Japan International Brands to drive unmatched media efficiency for YouTube campaign

SINGAPORE,Feb. 5,2025--Dentsu Japan International Brands Inc. (DJIB),the leading agency in the Japanese advertising market,has partnered with Channel Factory,a specialist in contextual targeting and m

Focus

Feb 7, 2025

SunCar Technology Group Announces Pricing of $50 Million Follow-On Public Offering of Class A Ordinary Shares

NEW YORK,Feb. 6,2025-- SunCar Technology Group Inc. ("SunCar") (Nasdaq: SDA),an innovative leader in cloud-based B2B auto services and auto e-insurance in China,today announced the pricing o

Focus

Feb 7, 2025

Strong stakeholder engagement towards Minesto's first tidal energy Dragon farm in Hestfjord, Faroe Islands

GOTHENBURG,Sweden,Feb. 6,2025-- On Monday 3rd February,ocean energy developer Minesto welcomed Faroese stakeholders,authorities as well as the public to a seminar at the Nordic House in Torshavn. Mart

Focus

Feb 7, 2025

Autohome Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

BEIJING,Feb. 6,2025-- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"),a leading online destination for automobile consumers in China,today announced that it wi

Focus

Feb 7, 2025

The View From the World's Largest Humanitarian Aid Hub - Dubai Humanitarian: Children Suffered Most From Global Crises in 2024

- Over $137m of aid distributed to 106 countries from Dubai Humanitarian aid hub used by international organisations including UNICEF,IFRC,WHO and WFP

Focus

Feb 7, 2025
1 ... 79 80 81 82 83 84 85 ... 117